시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 유전자 도입 기술 시장 보고서(2025년)
Gene Transfer Technologies Global Market Report 2025
상품코드 : 1889391
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,505,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,403,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,301,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 유전자 도입 기술 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 39억 7,000만 달러에서 2025년에는 45억 4,000만 달러로, CAGR 14.5%로 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 유전자 변형 연구에 대한 수요 증가, 맞춤형 의료에 대한 관심 증가, 생명 공학 연구에 대한 정부 자금 증가, 유전자 치료 임상시험 확대, 학술 및 산업계의 협력 강화와 관련이 있습니다.

유전자 도입 기술 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 77억 달러에 달하고 CAGR은 14.1%가 될 전망입니다. 예측기간의 성장은 첨단 유전자 전달 시스템의 채용 확대, 유전자 공학 및 합성 생물학에 대한 투자 증가, 희귀질환 치료에 응용 확대, 바이오 의약품 연구 개발 활동의 확대, 유전자 기반 요법에 대한 규제면의 지원 강화에 의해 견인될 전망입니다. 예측기간의 주요 동향으로는 유전자 편집 툴의 기술적 진보, 바이러스성 및 비바이러스성 벡터의 지속적인 혁신, 유전자 전달 플랫폼의 연구개발 증가, 차세대 유전자 도입 시스템의 개발, 정밀 유전공학 기술의 진보 등을 들 수 있습니다.

유전자 질환의 유병률 상승이 유전자 도입 기술 시장의 성장을 견인할 것으로 예측됩니다. 유전자 질환은 정상적인 생물학적 기능을 손상시키는 하나 이상의 유전자 또는 염색체의 변화에 기인합니다. 유병률 증가의 주요 요인은 진단 및 보고 체제의 개선, 고령화 사회의 진전, 임상 케어의 향상에 의한 이환 유아의 생존율 상승에 있습니다. 유전자 도입 기술은 결함이 있는 유전자의 표적화 전달 및 수정을 가능하게 하고, 유전자 치료, 정밀 치료 및 고급 연구 능력의 개발을 지원합니다. 예를 들어, 2025년 2월에 세계보건기구(WHO)가 보고한 바에 따르면, 세계 3억명 이상이 희소질환을 갖고 생활하고 있으며, 그 약 70%는 소아기에 발병하고 있습니다. 이 증가 경향이 유전자 도입 기술에 대한 수요를 촉진하고 있습니다.

유전자 도입 기술 시장의 기업은 세포 및 유전자 치료의 개발 가속, 확장성의 향상, 규제 준수의 확보를 목적으로 첨단 제조 플랫폼과 통합형 위탁 개발 제조 기관(CDMO) 서비스에 대한 투자를 추진하고 있습니다. 통합 CDMO 서비스는 제품 개발, 공정 최적화 및 대규모 제조를 단일 공급자 내에서 통합하여 생산 효율성과 시장 출시 시간을 단축합니다. 예를 들어, 2025년 10월에는 미국에 거점을 둔 바이오 의약품 CDMO인 AGC Biologics가 플라스미드 DNA, 바이러스 벡터, 세포요법에 있어서의 엔드 투 엔드의 개발 및 제조 능력을 강화하기 위해 전용 세포 및 유전자 치료 사업 부문을 시작했습니다. 이 이니셔티브는 공정 효율성 향상, 임상 단계에서 상업 규모로의 전환을 간소화하고 세계 유전 도입 요법의 혁신 지원을 목표로 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Gene transfer technologies refer to advanced techniques used to introduce foreign genetic material into cells to modify or regulate their genetic composition. These technologies are essential in developing gene therapies, conducting genetic research, and producing recombinant proteins. By enabling precise genetic alterations, they support the treatment of inherited disorders and the progress of personalized medicine.

The key products in gene transfer technologies include reagents, kits, and assays, consumables, instruments, and others. Reagents, kits, and assays refer to essential tools used to facilitate and monitor the gene transfer process by enabling the effective delivery and expression of genetic material in target cells. Various modes include viral methods such as retrovirus, adenovirus, and adeno-associated virus, as well as non-viral approaches like electroporation and gene gun techniques. The key methods include in vivo, ex vivo, and in vitro. Major applications include gene therapy, personalized medicine, regenerative medicine, and vaccine development, with primary end users such as academic and research institutes, biopharmaceutical companies, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The gene transfer technologies market research report is one of a series of new reports from The Business Research Company that provides gene transfer technologies market statistics, including the gene transfer technologies industry global market size, regional shares, competitors with the gene transfer technologies market share, detailed gene transfer technologies market segments, market trends, and opportunities, and any further data you may need to thrive in the gene transfer technologies industry. This gene transfer technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gene transfer technologies market size has grown rapidly in recent years. It will grow from $3.97 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be linked to increasing demand for genetic modification research, a growing focus on personalized medicine, rising government funding for biotechnology research, expansion of gene therapy clinical trials, and increasing academic and industry collaborations.

The gene transfer technologies market size is expected to see rapid growth in the next few years. It will grow to $7.70 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be driven by growing adoption of advanced gene delivery systems, rising investment in genetic engineering and synthetic biology, increasing applications in rare disease treatment, expansion of biopharmaceutical R&D activities, and growing regulatory support for gene-based therapies. Major trends in the forecast period include technological advancements in gene editing tools, continuous innovations in viral and non-viral vectors, increasing research and development in gene delivery platforms, the development of next-generation gene transfer systems, and advancements in precision genetic engineering techniques.

The rising prevalence of genetic disorders is expected to drive the growth of the gene transfer technologies market. Genetic disorders are caused by changes in one or more genes or chromosomes that impair normal biological functions. Their increasing prevalence is largely due to improved diagnosis and reporting, aging populations, and higher survival rates of affected infants resulting from better clinical care. Gene transfer technologies enable the targeted delivery and correction of faulty genes, supporting the development of gene therapies, precision treatments, and advanced research capabilities. For instance, in February 2025, the World Health Organization reported that over 300 million people globally live with rare diseases, approximately 70% of which originate in childhood. This rising prevalence is thus fueling demand for gene transfer technologies.

Companies in the gene transfer technologies market are investing in advanced manufacturing platforms and integrated contract development and manufacturing organization (CDMO) services to accelerate cell and gene therapy development, improve scalability, and ensure regulatory compliance. Integrated CDMO services combine product development, process optimization, and large-scale manufacturing within a single provider, streamlining production and reducing time-to-market. For example, in October 2025, AGC Biologics, a US-based biopharmaceutical CDMO, launched a dedicated Cell and Gene Therapy Business Division to strengthen its end-to-end development and manufacturing capabilities for plasmid DNA, viral vectors, and cell therapies. This initiative aims to enhance process efficiency, streamline clinical-to-commercial scale transition, and support innovation in gene transfer therapies worldwide.

In July 2024, Genezen, a US-based CDMO, acquired uniQure's commercial gene therapy operations for an undisclosed amount. Through this acquisition, Genezen aims to expand its commercial gene therapy capabilities and accelerate market access for advanced therapies. UniQure is a Netherlands-based biopharmaceutical company focused on developing and commercializing gene therapies for serious genetic diseases.

Major companies operating in the gene transfer technologies market are Thermo Fisher Scientific, Merck KGaA, Evonik Industries, Lonza Group AG, Agilent Technologies Inc., Charles River Laboratories, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Aldevron, Regenxbio Inc., CureVac AG, OriGene Technologies, Precision NanoSystems, 4D Molecular Therapeutics, Synthego Corporation, Addgene, Acuitas Therapeutics, Transposagen Biopharmaceuticals, Vigene Biosciences.

North America was the largest region in the gene transfer technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene transfer technologies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene transfer technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene transfer technologies market consists of revenues earned by entities by providing services such as cell line development services, regulatory and compliance support services, and custom assay development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene transfer technologies market also includes sales of electroporation devices, microinjection systems, cell culture media, and bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Transfer Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene transfer technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for gene transfer technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene transfer technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Gene Transfer Technologies Market Characteristics

3. Gene Transfer Technologies Market Trends And Strategies

4. Gene Transfer Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gene Transfer Technologies Growth Analysis And Strategic Analysis Framework

6. Gene Transfer Technologies Market Segmentation

7. Gene Transfer Technologies Market Regional And Country Analysis

8. Asia-Pacific Gene Transfer Technologies Market

9. China Gene Transfer Technologies Market

10. India Gene Transfer Technologies Market

11. Japan Gene Transfer Technologies Market

12. Australia Gene Transfer Technologies Market

13. Indonesia Gene Transfer Technologies Market

14. South Korea Gene Transfer Technologies Market

15. Western Europe Gene Transfer Technologies Market

16. UK Gene Transfer Technologies Market

17. Germany Gene Transfer Technologies Market

18. France Gene Transfer Technologies Market

19. Italy Gene Transfer Technologies Market

20. Spain Gene Transfer Technologies Market

21. Eastern Europe Gene Transfer Technologies Market

22. Russia Gene Transfer Technologies Market

23. North America Gene Transfer Technologies Market

24. USA Gene Transfer Technologies Market

25. Canada Gene Transfer Technologies Market

26. South America Gene Transfer Technologies Market

27. Brazil Gene Transfer Technologies Market

28. Middle East Gene Transfer Technologies Market

29. Africa Gene Transfer Technologies Market

30. Gene Transfer Technologies Market Competitive Landscape And Company Profiles

31. Gene Transfer Technologies Market Other Major And Innovative Companies

32. Global Gene Transfer Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Transfer Technologies Market

34. Recent Developments In The Gene Transfer Technologies Market

35. Gene Transfer Technologies Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기